ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 46 of 105 for:    Recruiting, Not yet recruiting, Available Studies | "Muscular Dystrophies"

Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03531788
Recruitment Status : Recruiting
First Posted : May 22, 2018
Last Update Posted : September 13, 2018
Sponsor:
Information provided by (Responsible Party):
Roxanna Marie Bendixen, University of Pittsburgh

Brief Summary:
This study is a longitudinal, randomized control trial evaluating the use of two commercially available dynamic arm support devices (Armon Ayura-Kinova and JAECO WREX) to promote participation in activities of daily living in non-ambulatory individuals with Duchenne muscular dystrophy (DMD) with upper extremity weakness.

Condition or disease Intervention/treatment Phase
Duchenne Muscular Dystrophy Device: Armon Ayura (Kinova) Device: JAECO Wrex Not Applicable

Detailed Description:
This study is a longitudinal, randomized control trial evaluating the use of two commercially available dynamic arm support devices (Armon Ayura-Kinova and JAECO WREX) to promote participation in activities of daily living in non-ambulatory individuals with Duchenne muscular dystrophy (DMD) with upper extremity weakness. Up to 30 individuals will be enrolled to participate in this research study, which includes a two-week baseline data collection period, a four-week device trial and a two-week post device data collection period. Participants will be randomly assigned to trial one of the dynamic arm support devices during the four week in-home trial. The ActiGraph, a wrist worn activity monitoring device, will be worn during the baseline period, the device trial and the post device data collection period to capture UE movement patterns. UE performance will be further quantified with use of a physical motor assessment, the Performance of Upper Limb (PUL) assessment and patient reported outcomes. Data gleaned will provide important knowledge and objective results regarding the potential benefit of dynamic arm supports in individuals with DMD with limited functional use of their upper extremities.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomly assigned to trial a dynamic arm support (Armon Ayura (Kinova) or JAECO WREX)
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Use of Dynamic Arm Support Devices for Upper Limb Function in Non-Ambulatory Men With Duchenne Muscular Dystrophy (DMD)
Actual Study Start Date : August 30, 2018
Estimated Primary Completion Date : October 31, 2019
Estimated Study Completion Date : December 31, 2019


Arm Intervention/treatment
Experimental: Armon Ayura (Kinova)
Participants will trial the Armon Ayura dynamic arm support.
Device: Armon Ayura (Kinova)
Actively assisted mechanical arm support (electric powered to balance arm)
Other Name: Kinova

Experimental: JAECO WREX
Participants will trial the JAECO Wilmington Robotic EXoskeleton (WREX) dynamic arm support.
Device: JAECO Wrex
Passive mechanical arm support (elastic bands to balance arm)




Primary Outcome Measures :
  1. Change in Upper Extremity Acceleration through Actigraphy [ Time Frame: Activity monitoring occurs throughout the trial period from baseline to 8 weeks ]
    Measured through the ActiGraph GT9X wrist worn activity monitoring device - The multi-axis accelerometer measures acceleration normalized to Earth gravity (g) in the x, y, and z axis.

  2. Change in Upper Extremity Position through Actigraphy [ Time Frame: Activity monitoring occurs throughout the trial period from baseline to 8 weeks ]
    Measured through the ActiGraph GT9X wrist worn activity monitoring device - The multi-axis gyroscope measures angular rates in degrees per second in the x, y, and z axis.


Secondary Outcome Measures :
  1. Goal Attainment Scale (GAS) [ Time Frame: The GAS will be completed and scored at baseline, then scored again at 6 weeks ]
    The GAS is a personal interview which allows the individual to determine important and personally meaningful goals. Goal scaling is standardized in order to calculate the extent to which a patient's goals are met.The GAS uses a 5-point rating scale to determine if the goal was not met (-2) up to a greater than expected meeting of the personal goal (+2). A score of 0 indicates the goal was met as anticipated.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. 14 years of age or older
  2. Self-report diagnosis of Duchenne muscular dystrophy (DMD)
  3. Use a wheelchair for mobility
  4. Score 3-5 on the Brooke UE Scale
  5. Self-report of needs assistance/unable to achieve independently on at least 10 items on the UL ADL self-report questionnaire
  6. Able to follow instructions
  7. Informed consent provided by self (18 and over) or by parent or legal guardian (if under the age of 18)

Exclusion Criteria:

  1. Does not have minimum level of UE function to operate the assigned dynamic arm support (Score of 6 on the Brooke UE scale or any other impairment limiting use)
  2. The assigned dynamic arm support is unable to be mounted to wheelchair (mounts will vary based on manufacturer/model of wheelchair)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03531788


Contacts
Contact: Roxanna M Bendixen, PhD 412-383-5045 bendixen@pitt.edu

Locations
United States, Pennsylvania
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15260
Contact: Annmarie Kelleher, MS    412-383-5045      
Sponsors and Collaborators
Roxanna Marie Bendixen
Investigators
Principal Investigator: Roxanna M Bendixen, PhD University of Pittsburgh

Responsible Party: Roxanna Marie Bendixen, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT03531788     History of Changes
Other Study ID Numbers: 18010005
First Posted: May 22, 2018    Key Record Dates
Last Update Posted: September 13, 2018
Last Verified: July 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: No

Keywords provided by Roxanna Marie Bendixen, University of Pittsburgh:
dynamic arm support
mobile arm support
rehabilitation
occupational therapy

Additional relevant MeSH terms:
Muscular Dystrophies
Muscular Dystrophy, Duchenne
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked